Allergy Therapeutics
AGY.L
#7060
Rank
A$0.65 B
Marketcap
$0.14
Share price
3.20%
Change (1 day)
126.72%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2024: -A$81.97 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are A$69.84 Million. In 2024 the company made an earning of -A$81.97 Million, an increase over its 2023 earnings that were of -A$87.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024-A$81.97 Million-5.94%
2023-A$87.15 Million243.12%
2022-A$25.4 Million-403.33%
2021A$8.37 M-49.05%
2020A$16.43 M82.31%
2019A$9.01 M-159.83%
2018-A$15.07 Million255.37%
2017-A$4.24 Million-84.22%
2016-A$26.87 Million-1678.94%
2015A$1.7 M-44.28%
2014A$3.05 M129.45%
2013A$1.33 M-19.85%
2012A$1.66 M-127%
2011-A$6.16 Million2044.94%
2010-A$0.29 Million-99.08%
2009-A$31.16 Million-53.32%
2008-A$66.74 Million-21.76%
2007-A$85.3 Million351.81%
2006-A$18.88 Million230.51%
2005-A$5.72 Million-219.33%
2004A$4.78 M-58.79%
2003A$11.61 M-196.03%
2002-A$12.1 Million